EROSIVE PUSTULAR DERMATOSIS

EROSIVE PUSTULAR DERMATOSIS was reported 50 times

EROSIVE PUSTULAR DERMATOSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Sulfone [EPC] 2 0.0002
1 Tetracycline-class Drug [EPC] 8 0.0001
2 Vitamin D Analog [EPC] 2 0.0001
3 Alkaloid [EPC] 2 0.0001
4 Platinum-based Drug [EPC] 19 0.0001
5 Folate Analog Metabolic Inhibitor [EPC] 23 0.0001
6 Vitamin D [EPC] 4 0.0000
7 Vitamin B12 [EPC] 4 0.0000
8 Retinoid [EPC] 3 0.0000
9 Programmed Death Receptor-1 Blocking Antibody [EPC] 1 0.0000
10 Vitamin C [EPC] 4 0.0000
11 Nucleoside Metabolic Inhibitor [EPC] 2 0.0000
12 Corticosteroid [EPC] 9 0.0000
13 Estrogen [EPC] 1 0.0000
14 RANK Ligand Inhibitor [EPC] 1 0.0000
15 Nonsteroidal Anti-inflammatory Drug [EPC] 5 0.0000
16 Kinase Inhibitor [EPC] 2 0.0000
17 Loop Diuretic [EPC] 1 0.0000